Electroencephalography in schizophrenic patients: Comparison between neuroleptic-naive state and after treatment

Biological Psychiatry

Volumn 40, Issue 6, 1996, Pages 452-456

  Nagase, Yasuko ^a   Okubo, Yoshiro ^a   Toru, Michio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Electroencephalography; Neuroleptic naive; Partial remission; Schizophrenia; Treatment

Indexed keywords

BIPERIDEN; BROMAZEPAM; BROMPERIDOL; BROTIZOLAM; CLOSPIPRAMINE; FLUNITRAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; NITRAZEPAM; PERPHENAZINE; PROMETHAZINE; SULPIRIDE; TRIHEXYPHENIDYL;

ADULT; ALPHA RHYTHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030587389     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00304-6     Document Type: Article

References (20)

1. Czobor P, Volavka J (1992): Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve. Psychiatry Res 42(2): 129-144.
2. Czobor P, Volavka J (1993): Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. J Clin Psychopharmacol 13(5):332-342.
3. Duffy FH, Barteles PH, Burchtiel JL (1981): Significance probability mapping: An aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 51: 455-462.
4. Fink M (1963): Quantitative EEG in human psychopharmacology: Drug patterns. In von Glaser (ed), EEG and Behavior. New York: Basic Books, pp 177-197.
5. Gattaz WF, Mayer S, Ziegler P, et al. (1992): Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters. Eur Arch Psychiatry Clin Neurosci 241(6):328-332.
6. Gunther W, Davous P, Godet JL, et al. (1988): Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping. Biol Psychiatry 23:295-311.
7. Itil TM (1977): Qualitative and quantitative EEG findings in schizophrenia. Schizoph Bull 3:61-79.
8. Kemali D, Vacca L, Marciano FL, et al. (1980): Computerized EEG in schizophrenics. Neuropsychobiology 6(5):260-267.
9. Kemali D, Galderisi S, Maj M, et al. (1992): Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment. Int J Psychophysiol 13(3):283-290.
10. Koukkou M (1981): EEG and behavioral differences between first acute schizophrenic episode and remission. In Perris C, Kemali D, Vacca L (eds), Advances in Biological Psychiatry, Vol. 6. Basel: Karger, p 35.
11. Morihisa JM, Duffy FH, McCarley RW (1983): BEAM in schizophrenic patients. Arch Gen Psychiatry 40:719-728.
12. Morstyn R, Duffy FH, McCarley RW (1983): Altered topography of EEG spectral content in schizophrenia. Electroencephalogr Clin Neurophysiol 56:263-271.
13. Nagase Y, Okubo Y, Matsuura M, et al (1992a): Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test. Biol Psychiatry 32:870-879.
14. Nagase Y, Okubo Y, Matsuura M, et al (1992b): EEG coherence in unmedicated schizophrenic patients. Topographical study of predominantly never medicated cases. Biol Psychiatry 32:1028-1034.
15. Roberts GW, Bruton CJ (1990): Notes from the graveyard: Neuropathology and schizophrenia. Neuropathol Appl Neurobiol 16(1):3-16.
16. Saletu B, Grunberger J, Linzmayer L (1977): Classification and determination of cerebral bioavailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS). Int J Clin Pharmacol Biopharm 15(10):449-459.
17. Saletu B, Kufferie B, Anderer P, et al. (1990): EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/ haloperidol. Eur-Neuropsychopharmacol 1(1):27-36.
18. Shagass C, Roemer RA, Straumanis JJ, et al. (1984): Psychiatric diagnostic discriminations with combinations of quantitative EEG variables. Br J Psychiatry 144:581-592.
19. Small JG, Milstein V, Small IF, et al. (1987): Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Clin-Electroencephalogr 18(3):124-135.
20. Toru M (1983): Pharmacology of Schizophrenics Tokyo: Chugai Medical Press.